FindTrial
Sign In

Prognostic Value of Prothrombin Fragments 1+2 for Pulmonary Embolism Incidence

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01078792
Enrollment
Unknown
Registered
2010-03-02
Start date
Unknown
Completion date
Unknown
Last updated
2010-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disease Exacerbation, Prothrombin Fragments, Pulmonary Disease, Chronic Obstructive, Pulmonary Embolism

Brief summary

To determine the possible association of prothrombin fragments 1+2 elevation with incidents of pulmonary embolism in patients with COPD exacerbation.

Interventions

OTHERCT pulmonary angio, blood tests

Sponsors

Hillel Yaffe Medical Center
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* COPD exacerbation * Able to give informed consent * Able to perform spirometry

Exclusion criteria

* Known malignancy * Known hypercoagulable state * Receiving anticoagulant treatment * Pregnancy * Renal failure * Allergy to Iodine

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026